Overview

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Status:
Recruiting

Trial end date:
2023-10-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of INCB099318 in select solid tumors.

Phase:

Phase 1

Details

Lead Sponsor:

Incyte Corporation